Douglas Melton , co-director of HSCI , and his team took skin cells from two type 1 diabetes patients , exposed the cells to a cocktail of three genes that reverted them back to an embryonic state -- which are referred to as pluripotent stem cells -- then instructed the newly reborn cells to grow into beta cells , the cells in the pancreas that secrete insulin .